Buy or sell Kaleido BioSciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Request Access
View More Companies

Kaleido BioSciences Stock

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

About Kaleido BioSciences Stock

Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.

Funding History

August 2015$4.5M
September 2017$60.0M
June 2018$101M

Press

Other Companies

Freenome Logo
Learn More
Learn More
Freenome
Freenome is a platform that helps design healthy conditions for an individual based on his/her cell-free genome
5Age (years)
$77.5MTotal Funding
Nimbus Therapeutics Logo
Learn More
Learn More
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
11Age (years)
$137MTotal Funding
Skipping Rocks Lab Logo
Learn More
Learn More
Skipping Rocks Lab
Skipping Rocks Lab is a young startup based in London.
6Age (years)
$850KTotal Funding
Synthorx Logo
Learn More
Learn More
Synthorx
Biotechnology
6Age (years)
$79.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kaleido BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo